IABS/Flanders Vaccine meeting Report: The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment

On September 19 & 20, 2023, the IABS/ Flanders Vaccine meeting on “The Role of Real-World Evidence for Regulatory and Public Health Decision Making for Accelerated Vaccine Deployment” took place, paving the way for impactful discussions and insights.

We are pleased to announce that the open access version of the article “The Role of Real-World Evidence for Regulatory and Public Health Decision-Making for Accelerated Vaccine Deployment – A Meeting Report” is now available online!


The COVID-19 pandemic underscored the need for rapid evidence generation to inform public health decisions beyond the limitations of conventional clinical trials. This report summarises presentations and discussions from a conference on the role of Real-World Evidence (RWE) in expediting vaccine deployment. Attended by regulatory bodies, public health entities, and industry experts, the gathering was a collaborative exchange of experiences and recommendations for leveraging RWE for vaccine deployment.

RWE proved instrumental in refining decision-making processes to optimise dosing regimens, enhance guidance on target populations, and steer vaccination strategies against emerging variants. Participants felt that RWE was successfully integrated into lifecycle management, encompassing boosters and safety considerations. However, challenges emerged, prompting a call for improvements in data quality, standardisation, and availability, acknowledging the variability and potential inaccuracies in data across diverse healthcare systems. Regulatory transparency should also be prioritised to foster public trust, and improved collaborations with governments are needed to streamline data collection and navigate data privacy regulations. Moreover, building and sustaining resources, expertise, and infrastructure in LMICs emerged as imperative for RWE-generating capabilities. Continued stakeholder collaboration and securing adequate funding emerged as vital pillars for advancing the use of RWE in shaping responsive and effective public health strategies.

Read the complete report here.